Arca
Skip to content
Tools
Tools

HepaFat-AI

System, Nuclear Magnetic Resonance Imaging. 510(k) K201039, from Resonance Health Analysis Services Pty, Ltd. (Perth, AU). Product code LNH, class 2.

As of Nov 18, 2026, K201039 is an FDA 510(k) held by Resonance Health Analysis Services Pty, Ltd., substantially equivalent on Dec 7, 2020 after 231 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Dec 7, 2020
  • Review time: 231 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

HepaFat-AI is indicated to: • Assess the volumetric liver fat fraction, proton density fat fraction and steatosis grade in individuals with confirmed or suspected fatty liver disease; When interpreted by a trained physician, the results can be used to • monitor liver fat content in patients undergoing weight loss management and can be used to • aid in the assessment and screening of living donors…

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • Hepafat ScanK122035 · Resonance Health Analysis Services Pty, Ltd. · Dec 13, 2013

Cited as a Predicate

2 later 510(k) summaries name this device as a predicate
  • HepaFatSmart (V2.0.0)K231459 · Resonance Health Analysis Services Pty, Ltd. · Jun 20, 2023
  • LiverSmartK213776 · Resonance Health Analysis Services Pty, Ltd. · Dec 29, 2021

Other LNH Clearances

The newest 510(k)s for the same product code; their median review was 152 days; see every LNH device

Elsewhere

Record

Type
Traditional
Received
Apr 20, 2020
Review panel
Radiology
Regulation
21 CFR 892.1000

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.